DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
50 hedge funds and large institutions have $177M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 5 closing their positions.
3% more capital invested
Capital invested by funds: $171M → $177M (+$5.46M)
0% more funds holding
Funds holding: 50 → 50 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$3.01M |
| 2 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
+$2.72M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$1.27M |
| 4 |
DAM
Deltec Asset Management
New York
|
+$1.25M |
| 5 |
CAC
Cowen and Company
New York
|
+$1.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$2.64M |
| 2 |
JP Morgan Chase
New York
|
-$2.53M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.46M |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
-$1.01M |
| 5 |
ETH
Exos TFP Holdings
New York
|
-$980K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
JP Morgan Chase
New York
| – | -$2.53M | -250,000 | Closed |
|
|
SCM
52
Segantii Capital Management
Hong Kong
| – | -$1.01M | -100,000 | Closed |
|
|
VF
53
Virtu Financial
New York
| – | -$284K | -28,100 | Closed |
|
|
CCM
54
Condor Capital Management
Martinsville,
New Jersey
| – | -$164K | -16,250 | Closed |
|
|
TSS
55
Two Sigma Securities
New York
| – | -$112K | -11,058 | Closed |
|
DALS Hedge Fund Activity: Q2 2023 in Review
50 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q2 2023, worth a combined $177M — up 3.2% from $171M a quarter earlier.
Fund positioning in DALS was balanced in Q2 2023: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 15 trimmed.
The largest buyer was Wealthspring Capital, adding an estimated $3.01M. The largest seller was Magnetar Financial, cutting an estimated $2.64M.
- 50 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $177M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q2 2023, up 3.2% quarter-over-quarter.
- 5 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q2 2023 and 5 closed out, a net change of 0 holders.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q2 2023 was Wealthspring Capital, an estimated $3.01M added.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q2 2023 was Magnetar Financial, an estimated $2.64M sold.
Based on aggregated 13F filings for Q2 2023.